FOXP3 expression is upregulated in CD4+T cells in progressive HIV-1 infection and is a marker of disease severity

PLoS ONE

Volumn 5, Issue 7, 2010, Pages

  Suchard, Melinda S ^a,c   Mayne, Elizabeth ^a,c   Green, Victoria A ^a,b,c   Shalekoff, Sharon ^c   Donninger, Samantha L ^c   Stevens, Wendy S ^a   Gray, Clive M ^c   Tiemessen, Caroline T ^c  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b University of Bath   (United Kingdom)

^c National Institute for Communicable Disease   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR FOXP3; ANTIBODY; CD3 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; INTERLEUKIN 2 RECEPTOR ALPHA; LEUKOCYTE ANTIGEN; NERVE GROWTH FACTOR RECEPTOR; TNFRSF18 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; UPREGULATION; VIRUS LOAD; CASE CONTROL STUDY; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECT; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METABOLISM; MONONUCLEAR CELL; PATHOPHYSIOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTIBODIES; ANTIGENS, CD; ANTIGENS, CD3; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HIV INFECTIONS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LEUKOCYTES, MONONUCLEAR; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77955399695     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011762     Document Type: Article

References (84)

1. Savarino A, Bottarel F, Malavasi F, Dianzani U (2000) Role of CD38 in HIV-1 infection: an piphenomenon of T-cell activation or an active player in virus/ host interactions? AIDS 14: 079-1089.
2. Sousa AE, Carneiro J, Meier-Schellersheim M, Grossman Z, Victorino RM (2002) CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 ut only indirectly to the viral load. J Immunol 169: 3400-3406.
3. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic selftolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155: 1151-1164.
4. Oswald-Richter K, Grill SM, Shariat N, Leelawong M, Sundrud MS, et al. (2004) HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol 2: E198.
5. + lymphocytes from HIVpositive patients. J Acquir Immune Defic Syndr 39: 381-385.
6. Kinter AL, Hennessey M, Bell A, Kern S, Lin Y, et al. (2004) CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J Exp Med 200: 331-343.
7. + CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol 78: 2454-2459.
8. +CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 104: 3249-3256.
9. Lim A, Tan D, Price P, Kamarulzaman A, Tan HY, et al. (2007) Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy. AIDS 21: 1525-1534.
10. + regulatory T cells in antiretroviral-naive HIV patients. AIDS 20: 1669-1671.
11. + regulatory T cells in patients chronically infected with human immunodeficiency virus and/or hepatitis C virus. Clin Exp Immunol 155: 35-43.
12. Gaardbo JC, Nielsen SD, Vedel SJ, Ersboll AK, Harritshoj L, et al. (2008) Regulatory T cells in human immunodeficiency virus-infected patients are elevated and independent of immunological and virological status, as well as initiation of highly active anti-retroviral therapy. Clin Exp Immunol 154: 80-86.
13. Kolte L, Gaardbo JC, Skogstrand K, Ryder LP, Ersboll AK, et al. (2009) Increased levels of regulatory T cells (Tregs) in human immunodeficiency virusinfected patients after 5 years of highly active anti-retroviral therapy may be due to increased thymic production of naive Tregs. Clin Exp Immunol 155: 44-52.
14. +CD25+ regulatory T cells to immune status in HIVinfected patients. AIDS 19: 879-886.
15. Kornbluth RS, Stone GW (2006) Immunostimulatory combinations: designing the next generation of vaccine adjuvants. J Leukoc Biol 80: 1084-1102.
16. Chougnet C, Gessani S (2006) Role of gp120 in dendritic cell dysfunction in HIV infection. J Leukoc Biol 80: 994-1000.
17. Granelli-Piperno A, Golebiowska A, Trumpfheller C, Siegal FP, Steinman RM (2004) HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. Proc Natl Acad Sci U S A 101: 7669-7674.
18. Krathwohl MD, Schacker TW, Anderson JL (2006) Abnormal presence of semimature dendritic cells that induce regulatory T cells in HIV-infected subjects. J Infect Dis 193: 494-504.
19. + T cells, and induce long-term organ allograft survival in combination with CTLA4- Ig. J Immunol 177: 5868-5877.
20. Manches O, Munn D, Fallahi A, Lifson J, Chaperot L, et al. (2008) HIVactivated human plasmacytoid DCs induce Tregs through an indoleamine 2,3- dioxygenase-dependent mechanism. J Clin Invest 118: 3431-3439.
21. + T cells to activate dendritic cells is reversed by restoration of CD40/CD154 interactions. Blood 107: 1989-1995.
22. + regulatory T cells by 1,25-dihydroxyvitamin D3. Blood 106: 3490-3497.
23. Benson MJ, Pino-Lagos K, Rosemblatt M, Noelle RJ (2007) All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J Exp Med 204: 1765-1774.
24. + regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 204: 1757-1764.
25. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, et al. (2007) Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317: 256-260.
26. Sun CM, Hall JA, Blank RB, Bouladoux N, Oukka M, et al. (2007) Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 204: 1775-1785.
27. Chen W, Liang X, Peterson AJ, Munn DH, Blazar BR (2008) The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cellinduced adaptive T regulatory cell generation. J Immunol 181: 5396-5404.
28. Fallarino F, Grohmann U, Hwang KW, Orabona C, Vacca C, et al. (2003) Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 4: 1206-1212.
29. Fallarino F, Grohmann U, You S, McGrath BC, Cavener DR, et al. (2006) Tryptophan catabolism generates autoimmune-preventive regulatory T cells. Transpl Immunol 17: 58-60.
30. Goleva E, Cardona ID, Ou LS, Leung DY (2005) Factors that regulate naturally occurring T regulatory cell-mediated suppression. J Allergy Clin Immunol 116: 1094-1100.
31. Nilsson J, Boasso A, Velilla PA, Zhang R, Vaccari M, et al. (2006) HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood 108: 3808-3817.
32. Sansom DM, Manzotti CN, Zheng Y (2003) What's the difference between CD80 and CD86? Trends Immunol 24: 314-319.
33. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, et al. (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27: 20-21.
34. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, et al. (2001) Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 27: 68-73.
35. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, et al. (2001) X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27: 18-20.
36. Ziegler SF (2006) FOXP3: of mice and men. Annu Rev Immunol 24: 209-226.
37. Fazekas de St Groth B, Landay AL (2008) Regulatory T cells in HIV infection: pathogenic or protective participants in the immune response? AIDS 22: 671-683.
38. Firan M, Dhillon S, Estess P, Siegelman MH (2006) Suppressor activity and potency among regulatory T cells is discriminated by functionally active CD44. Blood 107: 619-627.
39. Eggena MP, Barugahare B, Jones N, Okello M, Mutalya S, et al. (2005) Depletion of regulatory T cells in HIV infection is associated with immune activation. J Immunol 174: 4407-4414.
40. Huehn J, Hamann A (2005) Homing to suppress: address codes for Treg migration. Trends Immunol 26: 632-636.
41. Seddiki N, Kelleher AD (2008) Regulatory T cells in HIV infection: who's suppressing what? Curr HIV/AIDS Rep 5: 20-26.
42. Legrand FA, Nixon DF, Loo CP, Ono E, Chapman JM, et al. (2006) Strong HIV-1-specific T ell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal. PLoS One 1: e102.
43. + T reg cells. J Exp Med 203: 1701-1711.
44. Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, et al. (2006) Expression of nterleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 203: 1693-1700.
45. Levy Y (2006) Cytokine-based modulation of immune function in HIV infection. Curr Opin HIV AIDS 1: 69-73.
46. Sereti I, Imamichi H, Natarajan V, Imamichi T, Ramchandani MS, et al. (2005) In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2- treated HIV-infected patients. J Clin Invest 115: 1839-1847.
47. Fritzsching B, Oberle N, Pauly E, Geffers R, Buer J, et al. (2006) Naïve regulatory T cells: a novel subpopulation defined by resistance toward CD95Lmediated cell death. Blood 108: 3371-3378.
48. Seddiki N, Santner-Nanan B, Tangye SG, Alexander SI, Solomon M, et al. (2006) Persistence of naive CD45RA+ regulatory T cells in adult life. Blood 107: 2830-2838.
49. Valmori D, Merlo A, Souleimanian NE, Hesdorffer CS, Ayyoub M (2005) A peripheral circulating compartment of natural naive CD4 Tregs. J Clin Invest 115: 1953-1962.
50. +CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198: 1875-1886.
51. +CD25 - precursors. Am J Transplant 4: 1614-1627.
52. Pillai V, Ortega SB, Wang CK, Karandikar NJ (2007) Transient regulatory Tcells: a state attained by all activated human T-cells. Clin Immunol 123: 18-29.
53. +CD25- T cells. J Clin Invest 112: 1437-1443.
54. + regulatory T cells are derived by rapid turnover of memory populations in vivo. J Clin Invest 116: 2423-2433.
55. Luth S, Huber S, Schramm C, Buch T, Zander S, et al. (2008) Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs. J Clin Invest 118: 3403-3410.
56. Gavin MA, Torgerson TR, Houston E, DeRoos P, Ho WY, et al. (2006) Singlecell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell evelopment. Proc Natl Acad Sci U S A 103: 6659-6664.
57. +CD25+ T regulatory cells in humans. Hum Immunol 66: 13-20.
58. +FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 110: 2983-2990.
59. + T cells. Eur J Immunol 37: 129-138.
60. + T-cell enumeration. Cytometry 50: 69-77.
61. Bisikirska B, Colgan J, Luban J, Bluestone JA, Herold KC (2005) TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs. J lin Invest 115: 2904-2913.
62. Hoji A, Coro A, Ng HL, Jamieson BD, Yang OO (2008) Proliferation and foxp3 expression in virus-specific memory CD8+ T lymphocytes. AIDS Res Hum Retroviruses 24: 1087-1095.
63. Mahic M, Henjum K, Yaqub S, Bjornbeth BA, Torgersen KM, et al. (2008) Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation. Eur J Immunol 38: 640-646.
64. Sharabi A, Mozes E (2008) The suppression of murine lupus by a tolerogenic peptide involves foxp3-expressing CD8 cells that are required for the optimal induction and function of foxp3-expressing CD4 cells. J Immunol 181: 3243-3251.
65. + regulatory T cells with disease progression in antiretroviral-naive HIV-1 infected Chinese. Jpn J Infect Dis 61: 391-392.
66. Billerbeck E, Thimme R (2008) CD8+ regulatory T cells in persistent human viral infections. Hum Immunol 69: 771-775.
67. Jiang H, Wu Y, Liang B, Zheng Z, Tang G, et al. (2005) An affinity/avidity model of peripheral T cell regulation. J Clin Invest 115: 302-312.
68. +CD25+ T cell cultures upon polyclonal stimulation ex vivo. J Immunol 181: 8767-8775.
69. Koch SD, Uss E, van Lier RA, ten Berge IJ (2008) Alloantigen-induced regulatory CD8+CD103+ T cells. Hum Immunol 69: 737-744.
70. Boasso A, Vaccari M, Hryniewicz A, Fuchs D, Nacsa J, et al. (2007) Regulatory T-cell markers, indoleamine 2,3-dioxygenase, and virus levels in spleen and gut during progressive imian immunodeficiency virus infection. J Virol 81: 11593-11603.
71. Burl S, Hill PC, Jeffries DJ, Holland MJ, Fox A, et al. (2007) FOXP3 gene expression in a uberculosis case contact study. Clin Exp Immunol 149: 117-122.
72. +CD25+ T regulatory cells and TGF-beta in mucosal mmune system: the good and the bad. Curr Med Chem 14: 2245-2249.
73. Gazzola L, Tincati C, Gori A, Saresella M, Marventano I, et al. (2006) FoxP3 mRNA pression in regulatory T cells from patients with tuberculosis. Am J Respir Crit Care Med 174: 356; author reply 357.
74. Guyot-Revol V, Innes JA, Hackforth S, Hinks T, Lalvani A, (2006) Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med 173: 803-810.
75. Hougardy JM, Place S, Hildebrand M, Drowart A, Debrie AS, et al. (2007) Regulatory T cells depress immune responses to protective antigens in active tuberculosis. Am J Respir Crit Care Med 176: 409-416.
76. +CD127low/- regulatory T cells from peripheral blood lymphocytes of healthy Mycobacterium tuberculosis-infected humans. Microbes Infect 9: 1325-1332.
77. Jaron B, Maranghi E, Leclerc C, Majlessi L (2008) Effect of attenuation of Treg during BCG immunization on anti-mycobacterial Th1 responses and protection against Mycobacterium tuberculosis. PLoS One 3: e2833.
78. Kursar M, Koch M, Mittrucker HW, Nouailles G, Bonhagen K, et al. (2007) Cutting Edge: Regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis. J Immunol 178: 2661-2665.
79. Li L, Lao SH, Wu CY (2007) Increased frequency of CD4(+)CD25(high) Treg cells inhibit BCG-specific induction of IFN-gamma by CD4(+) T cells from TB patients. Tuberculosis (Edinb) 87: 526-534.
80. +CD25+ regulatory T ymphocytes in tuberculous pleural effusion. Chin Med J (Engl) 121: 581-586.
81. +CD25+ T cells in regulation of the immune response during human tuberculosis. Clin Exp Immunol 144: 25-34.
82. Scott-Browne JP, Shafiani S, Tucker-Heard G, Ishida-Tsubota K, Fontenot JD, et al. (2007) Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J Exp Med 204: 2159-2169.
83. Wu B, Huang C, Kato-Maeda M, Hopewell PC, Daley CL, et al. (2007) Messenger RNA expression of IL-8, FOXP3, and IL-12beta differentiates latent tuberculosis infection from isease. J Immunol 178: 3688-3694.
84. Roberts T, Beyers N, Aguirre A, Walzl G (2007) Immunosuppression during active uberculosis is characterized by decreased interferon- gamma production and CD25 expression with elevated forkhead box P3, transforming growth factor- beta, and interleukin- mRNA levels. J Infect Dis 195: 870-878.